These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15531098)

  • 1. Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate.
    Tamás A; Gábriel R; Rácz B; Dénes V; Kiss P; Lubics A; Lengvári I; Reglodi D
    Neurosci Lett; 2004 Nov; 372(1-2):110-3. PubMed ID: 15531098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pituitary adenylate cyclase activating polypeptide and its fragments on retinal degeneration induced by neonatal monosodium glutamate treatment.
    Atlasz T; Szabadfi K; Reglodi D; Kiss P; Tamás A; Tóth G; Molnár A; Szabó K; Gábriel R
    Ann N Y Acad Sci; 2009 Apr; 1163():348-52. PubMed ID: 19456357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of systemic PACAP treatment in monosodium glutamate-induced behavioral changes and retinal degeneration.
    Kiss P; Tamás A; Lubics A; Lengvári I; Szalai M; Hauser D; Horvath ZS; Racz B; Gabriel R; Babai N; Toth G; Reglódi D
    Ann N Y Acad Sci; 2006 Jul; 1070():365-70. PubMed ID: 16888193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early postnatal enriched environment decreases retinal degeneration induced by monosodium glutamate treatment in rats.
    Szabadfi K; Atlasz T; Horváth G; Kiss P; Hamza L; Farkas J; Tamás A; Lubics A; Gábriel R; Reglodi D
    Brain Res; 2009 Mar; 1259():107-12. PubMed ID: 19171125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats.
    Atlasz T; Babai N; Kiss P; Reglodi D; Tamás A; Szabadfi K; Tóth G; Hegyi O; Lubics A; Gábriel R
    Gen Comp Endocrinol; 2007; 153(1-3):108-14. PubMed ID: 17289046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways.
    Rácz B; Gallyas F; Kiss P; Tóth G; Hegyi O; Gasz B; Borsiczky B; Ferencz A; Roth E; Tamás A; Lengvári I; Lubics A; Reglodi D
    Regul Pept; 2006 Nov; 137(1-2):20-6. PubMed ID: 16945433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Search for the optimal monosodium glutamate treatment schedule to study the neuroprotective effects of PACAP in the retina.
    Babai N; Atlasz T; Tamás A; Reglodi D; Tóth G; Kiss P; Gábriel R
    Ann N Y Acad Sci; 2006 Jul; 1070():149-55. PubMed ID: 16888157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between PACAP- and enriched environment-induced retinal protection in MSG-treated newborn rats.
    Kiss P; Atlasz T; Szabadfi K; Horvath G; Griecs M; Farkas J; Matkovits A; Toth G; Lubics A; Tamas A; Gabriel R; Reglodi D
    Neurosci Lett; 2011 Jan; 487(3):400-5. PubMed ID: 21050880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.
    Atlasz T; Szabadfi K; Kiss P; Tamas A; Toth G; Reglodi D; Gabriel R
    Brain Res Bull; 2010 Mar; 81(4-5):497-504. PubMed ID: 19751807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration.
    Atlasz T; Szabadfi K; Kiss P; Babai N; Koszegi Z; Tamas A; Reglodi D; Gabriel R
    J Mol Neurosci; 2008 Nov; 36(1-3):97-104. PubMed ID: 18418735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retinal degeneration.
    Babai N; Atlasz T; Tamás A; Reglödi D; Tóth G; Kiss P; Gábriel R
    Neurotox Res; 2005 Nov; 8(3-4):227-33. PubMed ID: 16371317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of ERK and CREB signaling pathways in the protective effect of PACAP in monosodium glutamate-induced retinal lesion.
    Rácz B; Tamás A; Kiss P; Tóth G; Gasz B; Borsiczky B; Ferencz A; Gallyas F; Roth E; Reglodi D
    Ann N Y Acad Sci; 2006 Jul; 1070():507-11. PubMed ID: 16891269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
    Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
    Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
    Reglodi D; Lubics A; Tamás A; Szalontay L; Lengvári I
    Behav Brain Res; 2004 May; 151(1-2):303-12. PubMed ID: 15084446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PACAP improves functional outcome in excitotoxic retinal lesion: an electroretinographic study.
    Varga B; Szabadfi K; Kiss P; Fabian E; Tamas A; Griecs M; Gabriel R; Reglodi D; Kemeny-Beke A; Pamer Z; Biro Z; Tosaki A; Atlasz T; Juhasz B
    J Mol Neurosci; 2011 Jan; 43(1):44-50. PubMed ID: 20567936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocortin 2 treatment is protective in excitotoxic retinal degeneration.
    Szabadfi K; Kiss P; Reglodi D; Fekete EM; Tamas A; Danyadi B; Atlasz T; Gabriel R
    Acta Physiol Hung; 2014 Mar; 101(1):67-76. PubMed ID: 24311224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanopsin is expressed in PACAP-containing retinal ganglion cells of the human retinohypothalamic tract.
    Hannibal J; Hindersson P; Ostergaard J; Georg B; Heegaard S; Larsen PJ; Fahrenkrug J
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4202-9. PubMed ID: 15505076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of monosodium glutamate on retinal vessel development and permeability in rats.
    Bellhorn RW; Lipman DA; Confino J; Burns MS
    Invest Ophthalmol Vis Sci; 1981 Aug; 21(2):237-47. PubMed ID: 7251307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
    Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
    Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective action of endogenous PACAP in cultured rat cortical neurons.
    Shintani N; Suetake S; Hashimoto H; Koga K; Kasai A; Kawaguchi C; Morita Y; Hirose M; Sakai Y; Tomimoto S; Matsuda T; Baba A
    Regul Pept; 2005 Mar; 126(1-2):123-8. PubMed ID: 15620425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.